ArticlePharmaceutics2022

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans.

Jin-Woo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.